Entities / Company
Fulcrum Therapeutics (United States).
company in Cambridge, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 24
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
Gone quiet
No new reports in 90+ days-
Fulcrum Therapeutics is developing small molecules for rare diseases, including those related to sickle cell disease, and has a director involved in the VCU Adult Sickle Cell Program.Some support1 report
-
Fulcrum Therapeutics, based in Cambridge, MA, is listed on the Nasdaq exchange.Some support4 reports
-
Fulcrum Therapeutics, based in Cambridge, MA, uses LinkedIn for company communication.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Fulcrum Therapeutics (United States) this week
News at the entities that move Fulcrum Therapeutics (United States) most-
LinkedIn Shared contextJon Gray is the president of Blackstone, while employees generally use LinkedIn for career development and business building.Moves Fulcrum Therapeutics (United States)
-
Cambridge Shared contextGrossi's upbringing is reported to have shaped his worldview.Moves Fulcrum Therapeutics (United States)
Connections
The 2 strongest of 24, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.History
Events by the month they beganJune 2026
4 events- Trump's pledge benefits 15 US stocks, including Descartes Systems Group.
- Fulcrum Therapeutics is developing small molecules for rare diseases, including those related to sickle cell disease, and has a director involved in the VCU Adult Sickle Cell Program.
- Fulcrum Therapeutics, based in Cambridge, MA, is listed on the Nasdaq exchange.
- Fulcrum Therapeutics, based in Cambridge, MA, uses LinkedIn for company communication.